glp-1 trials Receptor Agonists Clinical trials suggest GLP-1s may

On the regulatory side, the European Food Safety Authority (EFSA) has authorised a claim that glucomannan contributes to weight loss in the context of an energy-restricted diet at 3 g per day taken in three 1 g doses with water, subject to a mandatory choking warning for anyone with swallowing difficulty or inadequate fluid intake, and an authorised oat beta-glucan claim for maintenance of normal blood cholesterol at 3 g per day [6]

It works as a very selective GLP-1 receptor agonist and is very similar to human GLP-1 (94% similarity)

Disclaimer: Information and statements regarding the product/services have not been evaluated by the Food and Drug Administration or any government authority and not intended to diagnose, treat, cure, or prevent any disease_ Product/Services reviews are provided by users based on their persona, experiences & opinions, and do not reflect the opinion of HealthKart_ Product/Services information provided by the seller on HealthKart is not exhaustive, please read the label on the product carefully for complete information provided by the manufacturer_ The results from the products will vary from person to person_ No individual result should be seen as typical_ Ranked: #254 in Sports Nutrition

(PubMed) Polymeropoulos E, Bagos P, Papadimitriou M, Rizos I, Patsouris E, Tauoumpoulis I